tiprankstipranks
Trending News
More News >
LakeShore Biopharma (LSB)
NASDAQ:LSB
US Market
Advertisement

LakeShore Biopharma (LSB) Stock Statistics & Valuation Metrics

Compare
92 Followers

Total Valuation

LakeShore Biopharma has a market cap or net worth of $48.63M. The enterprise value is $323.18M.
Market Cap$48.63M
Enterprise Value$323.18M

Share Statistics

LakeShore Biopharma has 41,212,692 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,212,692
Owned by Insiders
Owned by Institutions

Financial Efficiency

LakeShore Biopharma’s return on equity (ROE) is -0.74 and return on invested capital (ROIC) is -41.04%.
Return on Equity (ROE)-0.74
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-41.04%
Return on Capital Employed (ROCE)-0.63
Revenue Per Employee756.49K
Profits Per Employee-571.85K
Employee Count758
Asset Turnover0.38
Inventory Turnover0.58

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio0.20
Price to Fair Value9.58
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio>-0.01

Income Statement

In the last 12 months, LakeShore Biopharma had revenue of 573.42M and earned -433.46M in profits. Earnings per share was -4.05.
Revenue573.42M
Gross Profit455.73M
Operating Income-445.83M
Pretax Income-455.19M
Net Income-433.46M
EBITDA-368.66M
Earnings Per Share (EPS)-4.05

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

LakeShore Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.03
52-Week Price Change-74.38%
50-Day Moving Average1.06
200-Day Moving Average2.15
Relative Strength Index (RSI)58.82
Average Volume (3m)571.54K

Important Dates

LakeShore Biopharma upcoming earnings date is Aug 19, 2025, Before Open (Not Confirmed).
Last Earnings DateApr 22, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date

Financial Position

LakeShore Biopharma as a current ratio of 1.13, with Debt / Equity ratio of 72.53%
Current Ratio1.13
Quick Ratio0.87
Debt to Market Cap0.07
Net Debt to EBITDA-0.48
Interest Coverage Ratio-10.05

Taxes

In the past 12 months, LakeShore Biopharma has paid -21.73M in taxes.
Income Tax-21.73M
Effective Tax Rate0.05

Enterprise Valuation

LakeShore Biopharma EV to EBITDA ratio is -15.69, with an EV/FCF ratio of -17.03.
EV to Sales10.08
EV to EBITDA-15.69
EV to Free Cash Flow-17.03
EV to Operating Cash Flow-19.59

Balance Sheet

LakeShore Biopharma has $246.35M in cash and marketable securities with ¥424.46M in debt, giving a net cash position of $178.11M billion.
Cash & Marketable Securities$246.35M
Total Debt¥424.46M
Net Cash$178.11M
Net Cash Per Share$4.32
Tangible Book Value Per Share$4.81

Margins

Gross margin is 55.29%, with operating margin of -77.75%, and net profit margin of -75.59%.
Gross Margin55.29%
Operating Margin-77.75%
Pretax Margin-79.38%
Net Profit Margin-75.59%
EBITDA Margin-64.29%
EBIT Margin-71.65%

Analyst Forecast

The average price target for LakeShore Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score1
AI Score39
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis